Literature DB >> 18584780

Cost-utility of vagus nerve stimulation (VNS) therapy for medically refractory epilepsy--an update.

Raeburn Forbes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18584780     DOI： 10.1016/j.seizure.2007.10.005

Source DB:  PubMed          Journal:  Seizure        ISSN： 1059-1311            Impact factor:   3.184


× No keyword cloud information.
  4 in total

1.  Surgical approaches to treating epilepsy in children.

Authors:  Trupti Jadhav; J Helen Cross
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

Review 2.  Corpus callosotomy versus vagus nerve stimulation for atonic seizures and drop attacks: A systematic review.

Authors:  John D Rolston; Dario J Englot; Doris D Wang; Paul A Garcia; Edward F Chang
Journal:  Epilepsy Behav       Date:  2015-08-03       Impact factor: 2.937

3.  One-year cost-effectiveness of callosotomy vs vagus nerve stimulation for drug-resistant seizures in Lennox-Gastaut Syndrome: A decision analytic model.

Authors:  Taylor J Abel; Madison Remick; William C Welch; Kenneth J Smith
Journal:  Epilepsia Open       Date:  2022-01-17

4.  Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.

Authors:  Molly F Purser; Deirdre M Mladsi; Alan Beckman; Francesca Barion; John Forsey
Journal:  Adv Ther       Date:  2018-08-24       Impact factor: 3.845
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.